BNP Paribas Financial Markets’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q1
Sell
-29,789
Closed -$85.8K 3681
2021
Q4
$85.8K Buy
+29,789
New +$85.8K ﹤0.01% 3001
2021
Q3
Sell
-16
Closed -$85 3449
2021
Q2
$85 Hold
16
﹤0.01% 3410
2021
Q1
$74 Hold
16
﹤0.01% 3384
2020
Q4
$53 Hold
16
﹤0.01% 3423
2020
Q3
$53 Sell
16
-51,586
-100% -$171K ﹤0.01% 3508
2020
Q2
$174K Buy
51,602
+44,507
+627% +$150K ﹤0.01% 1947
2020
Q1
$27.2K Buy
7,095
+3,793
+115% +$14.5K ﹤0.01% 3202
2019
Q4
$19.9K Buy
3,302
+655
+25% +$3.96K ﹤0.01% 3340
2019
Q3
$20K Buy
2,647
+2,588
+4,386% +$19.6K ﹤0.01% 3307
2019
Q2
$799 Sell
59
-206
-78% -$2.79K ﹤0.01% 3751
2019
Q1
$1.44K Hold
265
﹤0.01% 3539
2018
Q4
$787 Sell
265
-6
-2% -$18 ﹤0.01% 3274
2018
Q3
$2.21K Hold
271
﹤0.01% 3573
2018
Q2
$2.64K Sell
271
-2,299
-89% -$22.4K ﹤0.01% 3570
2018
Q1
$22.3K Buy
2,570
+50
+2% +$434 ﹤0.01% 3316
2017
Q4
$31.6K Buy
2,520
+1,407
+126% +$17.6K ﹤0.01% 3188
2017
Q3
$9.31K Sell
1,113
-82
-7% -$686 ﹤0.01% 3330
2017
Q2
$20.3K Buy
1,195
+1,194
+119,400% +$20.3K ﹤0.01% 3115
2017
Q1
$20 Hold
1
﹤0.01% 3447
2016
Q4
$16 Hold
1
﹤0.01% 3436
2016
Q3
$13 Hold
1
﹤0.01% 3526
2016
Q2
$7 Sell
1
-56
-98% -$392 ﹤0.01% 3550
2016
Q1
$539 Sell
57
-583
-91% -$5.51K ﹤0.01% 2553
2015
Q4
$6.44K Hold
640
﹤0.01% 3440
2015
Q3
$9.16K Buy
+640
New +$9.16K ﹤0.01% 3435